AxoGen, Inc
AxoGen, Inc., together with its subsidiaries, provides surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive Soft Tissue Membrane, a minimally processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues in the surgical bed. In addition, the company offers AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, the United Kingdom and other European countries, South Korea, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida. Show More...
-
Website http://www.axogeninc.com
-
Sector Healthcare
-
Industry Medical Devices
-
Last Quote 10.89 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -8.35 -2.77 -0.85 -1.08 -0.99 -0.51 -0.47 -0.31 -0.6 -0.74 -0.71 Dividends USD Payout Ratio % * Shares Mil 1.0 4.0 11.0 13.0 18.0 26.0 31.0 33.0 37.0 39.0 39.0 Book Value Per Share * USD 2.33 0.72 -0.25 0.24 -0.52 0.37 0.03 0.31 3.84 3.42 3.12 Free Cash Flow Per Share * USD -0.57 -0.88 -0.79 -0.97 -0.63 -0.51 -0.5 -0.33 -0.58 -0.66 Return on Assets % -9.77 -90.53 -57.56 -60.76 -80.35 -49.52 -34.35 -19.85 -20.45 -18.51 -18.22 Financial Leverage (Average) 1.01 2.05 202.62 4.58 3.11 2.34 1.09 1.17 1.17 Return on Equity % -12.48 -127.29 -580.99 -124.68 -52.09 -26.02 -20.88 -21.0 Return on Invested Capital % -12.64 -67.82 -49.36 -21.16 -17.93 -21.53 -20.6 -20.38 Interest Coverage -3.01 -3.27 -1.91 -1.24 -2.24 -1.3 -3.24 -17.54 -727.38 -487.12 Current Ratio 88.21 5.39 12.36 12.23 5.89 9.45 3.97 4.06 11.57 6.47 6.18 Quick Ratio 62.26 4.45 10.11 10.47 4.53 8.27 3.44 3.47 10.11 5.43 4.93 Debt/Equity 0.73 185.63 3.12 1.36 0.79 0.010 0.010